Table 10.
Variable | Component 1 | Component 2 | Component 3 | Component 4 |
---|---|---|---|---|
Sex | 0.383 | 0.034 | 0.797 | 0.116 |
Age | 0.644 | 0.154 | −0.195 | −0.025 |
Tumor location | 0.166 | 0.384 | −0.081 | −0.571 |
TNM stages | 0.434 | 0.324 | 0.512 | −0.327 |
MSI | −0.825 | −0.127 | 0.098 | −0.195 |
F. nucleatum | −0.012 | −0.029 | 0.091 | 0.760 |
HER-2 | 0.572 | 0.108 | 0.599 | −0.058 |
CD31 | 0.670 | 0.207 | −0.346 | −0.114 |
CgA | −0.012 | 0.908 | −0.060 | 0.246 |
Syn | −0.431 | 0.767 | −0.060 | 0.267 |
Notes: Bold values indicate strong and moderate loadings: Component 1 has strong positive loadings on Age, HER-2, CD31 and negative loadings on MSI; Component 2 has positive loadings on CgA, Syn; Component 3 has positive loadings on Sex,TNM stages and HER-2;Component 4 has positive loadings on F. nucleatum and negative loadings on Tumor location.
Abbreviations: CRC, colorectal cancer; F. nucleatum, Fusobacterium nucleatum; HER-2, human epidermal growth factor receptor-2; MSI, microsatellite instability; Syn, synaptophysin; CgA, chromogranin A.